Trial Profile
Study of triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2016
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 Dec 2016 New trial record